ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 154 filers reported holding ACORDA THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $34,902,000 | -19.3% | 815,838 | -50.0% | 6.05% | +36.7% |
| Q3 2015 | $43,256,000 | +59.1% | 1,631,676 | +100.0% | 4.42% | +34.1% |
| Q2 2015 | $27,192,000 | -21.8% | 815,838 | -21.9% | 3.30% | -25.2% |
| Q1 2015 | $34,770,000 | -17.6% | 1,044,783 | +1.2% | 4.41% | -20.3% |
| Q4 2014 | $42,206,000 | -32.7% | 1,032,700 | -44.2% | 5.53% | -36.2% |
| Q3 2014 | $62,714,000 | -99.9% | 1,851,077 | -4.2% | 8.68% | +9.8% |
| Q2 2014 | $65,107,966,000 | -12.2% | 1,931,414 | -1.3% | 7.90% | -6.7% |
| Q1 2014 | $74,167,655,000 | +29.8% | 1,956,414 | 0.0% | 8.47% | +7.7% |
| Q4 2013 | $57,127,288,000 | -16.0% | 1,956,414 | -1.7% | 7.86% | -19.0% |
| Q3 2013 | $68,036,078,000 | +3.3% | 1,989,359 | -0.4% | 9.70% | -14.6% |
| Q2 2013 | $65,863,479,000 | – | 1,996,468 | – | 11.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |